Age (years) | 77.6 ± 6.6 |
Weight (kg) | 79.1 ± 14.7 |
BMI (kg/m2) | 27.0 ± 4.9 |
Female gender, n (%) | 18/42(42.9%) |
NYHA functional class, n (%) | II 1/42(2.4%) |
III 40/42 (95.2%) | |
IV 1/42 (2.4%) | |
Etiology of the MR, n (%) | (1) Primary 23/42(54.8%) |
(2) Secondary 17/42(40.5%) | |
(3) Mixed 2/42(4.8%) | |
Chronic obstructive lung disease | 7/42 (16.7%) |
Asthma bronchiale | 1/42(2.4%) |
LVEF (%) | 48.2 ± 13.4 |
N-terminal pro-B-type natriuretic peptide (pg/ml) | 3367.7 ± 4718.0 |
EURO Score II | 5.0 ± 3.6 |
Pulmonary artery pressure (mmHg) | 48.8 ± 11.4 |
Glomerular filtration rate (mL/min/1.73 m2) | 53.2 ± 22.2 |
Vital capacity (ml/kg) | 85.3 ± 21.8 |
Left atrial diameter in M-Mode (mm) | 48.1 ± 8.0 |
Atrial fibrillation (AF), n (%) | 35 (83.3%) |